View More
Should patients with advanced HIV disease be started on INSTI-based regimens?
Chloe Orkin, MBChB, FRCP, MD
Released: April 17, 2018
What do the latest clinical data show about giving rifampin with dolutegravir, bictegravir, or tenofovir alafenamide?
Daniel R. Kuritzkes, MD
Released: April 27, 2018
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270
Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.